Comparison of Nanoparticle Penetration into Solid Tumors and Sites of Inflammation: Studies Using Targeted and Nontargeted Liposomes

References

• Kawasaki ES , PlayerA . Nanotechnology, nanomedicine, and the development of new, effective therapies for cancer . Nanomedicine1 ( 2 ), 101 – 109 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Leamon CP , CooperSR , HardeeGE . Folate-liposome-mediated antisense oligodeoxynucleotide targeting to cancer cells: evaluation in vitro and in vivo . Bioconjug. Chem.14 ( 4 ), 738 – 747 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Lee RJ , LowPS . Delivery of liposomes into cultured KB cells via folate receptor-mediated endocytosis . J. Biol. Chem.269 ( 5 ), 3198 – 3204 ( 1994 ).
   PubMed Web of Science ®Google Scholar
• Markman JL , RekechenetskiyA , HollerE , LjubimovaJY . Nanomedicine therapeutic approaches to overcome cancer drug resistance . Adv. Drug. Deliv. Rev.65 ( 13–14 ), 1866 – 1879 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Waite CL , RothCM . Nanoscale drug delivery systems for enhanced drug penetration into solid tumors: current progress and opportunities . Crit. Rev. Biomed. Eng.40 ( 1 ), 21 – 41 ( 2012 ).
   PubMedGoogle Scholar
• Wang R , BillonePS , MullettWM . Nanomedicine in action: an overview of cancer nanomedicine on the market and in clinical trials . J. Nanomaterials2013 , 12 ( 2013 ).
   Web of Science ®Google Scholar
• Xia W , LowPS . Folate-targeted therapies for cancer . J. Med. Chem.53 ( 19 ), 6811 – 6824 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Goodman TT , OlivePL , PunSH . Increased nanoparticle penetration in collagenase-treated multicellular spheroids . Int. J. Nanomedicine2 ( 2 ), 265 – 274 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Choi IK , StraussR , RichterM , YunCO , LieberA . Strategies to increase drug penetration in solid tumors . Front. Oncol.3 , 193 ( 2013 ).
   PubMedGoogle Scholar
• Yuan F , DellianM , FukumuraDet al. Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size . Cancer Res.55 ( 17 ), 3752 – 3756 ( 1995 ).
   PubMed Web of Science ®Google Scholar
• Pluen A , BoucherY , RamanujanSet al. Role of tumor-host interactions in interstitial diffusion of macromolecules: cranial vs. subcutaneous tumors . Proc. Natl Acad. Sci. USA98 ( 8 ), 4628 – 4633 ( 2001 ).
   PubMed Web of Science ®Google Scholar
• Grill J , LamfersML , Van BeusechemVWet al. The organotypic multicellular spheroid is a relevant three-dimensional model to study adenovirus replication and penetration in human tumors in vitro . Mol. Ther.6 ( 5 ), 609 – 614 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Emfietzoglou D , KostarelosK , PapakostasAet al. Liposome-mediated radiotherapeutics within avascular tumor spheroids: comparative dosimetry study for various radionuclides, liposome systems, and a targeting antibody . J. Nucl. Med.46 ( 1 ), 89 – 97 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Kostarelos K , EmfietzoglouD , PapakostasA , YangWH , BallangrudA , SgourosG . Binding and interstitial penetration of liposomes within avascular tumor spheroids . Int. J. Cancer112 ( 4 ), 713 – 721 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Dreher MR , LiuW , MichelichCR , DewhirstMW , YuanF , ChilkotiA . Tumor vascular permeability, accumulation, and penetration of macromolecular drug carriers . J. Natl Cancer Inst.98 ( 5 ), 335 – 344 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Cho K , WangX , NieS , ChenZG , ShinDM . Therapeutic nanoparticles for drug delivery in cancer . Clin. Cancer Res.14 ( 5 ), 1310 – 1316 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Turk MJ , ReddyJA , ChmielewskiJA , LowPS . Characterization of a novel pH-sensitive peptide that enhances drug release from folate-targeted liposomes at endosomal pHs . Biochim. Biophys. Acta1559 ( 1 ), 56 – 68 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Turk MJ , WatersDJ , LowPS . Folate-conjugated liposomes preferentially target macrophages associated with ovarian carcinoma . Cancer Lett.213 ( 2 ), 165 – 172 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Henne WA , RothenbuhlerR , Ayala-LopezW , XiaW , VargheseB , LowPS . Imaging sites of infection using a 99mTc-labeled folate conjugate targeted to folate receptor positive macrophages . Mol. Pharm.9 ( 5 ), 1435 – 1440 ( 2012 ).
   PubMedGoogle Scholar
• Yefimova SL , KurilchenkoIY , TkachevaTNet al. Comparative study of dye-loaded liposome accumulation in sensitive and resistant human breast cancer cells . Exp. Oncol.34 ( 2 ), 101 – 106 ( 2012 ).
   PubMedGoogle Scholar
• Paulos CM , TurkMJ , BreurGJ , LowPS . Folate receptor-mediated targeting of therapeutic and imaging agents to activated macrophages in rheumatoid arthritis . Adv. Drug. Deliv. Rev.56 ( 8 ), 1205 – 1217 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Turk MJ , BreurGJ , WidmerWRet al. Folate-targeted imaging of activated macrophages in rats with adjuvant-induced arthritis . Arthritis Rheum.46 ( 7 ), 1947 – 1955 ( 2002 ).
   PubMedGoogle Scholar
• Xia W , HilgenbrinkAR , MattesonEL , LockwoodMB , ChengJX , LowPS . A functional folate receptor is induced during macrophage activation and can be used to target drugs to activated macrophages . Blood113 ( 2 ), 438 – 446 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Lee RJ , LowPS . Folate-mediated tumor cell targeting of liposome-entrapped doxorubicin in vitro . Biochim. Biophys. Acta1233 ( 2 ), 134 – 144 ( 1995 ).
   PubMed Web of Science ®Google Scholar
• Lee RJ , WangS , TurkMJ , LowPS . The effects of pH and intraliposomal buffer strength on the rate of liposome content release and intracellular drug delivery . Biosci. Rep.18 ( 2 ), 69 – 78 ( 1998 ).
   PubMed Web of Science ®Google Scholar
• Vaitilingam B , ChelvamV , KularatneSA , PohS , Ayala-LopezW , LowPS . A folate receptor-alpha-specific ligand that targets cancer tissue and not sites of inflammation . J. Nucl. Med.53 ( 7 ), 1127 – 1134 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Vignaud A , HourdeC , Butler-BrowneG , FerryA . Differential recovery of neuromuscular function after nerve/muscle injury induced by crude venom from Notechis scutatus, cardiotoxin from Naja atra and bupivacaine treatments in mice . Neurosci. Res.58 ( 3 ), 317 – 323 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Varghese B , VlashiE , XiaWet al. Folate receptor-beta in activated macrophages: ligand binding and receptor recycling kinetics . Mol. Pharm.11 ( 10 ), 3609 – 3616 ( 2014 ).
   PubMedGoogle Scholar
• Zhao X , LiH , LeeRJ . Targeted drug delivery via folate receptors . Expert Opin. Drug Deliv.5 ( 3 ), 309 – 319 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Shen J , HilgenbrinkAR , XiaWet al. Folate receptor-beta constitutes a marker for human proinflammatory monocytes . J. Leukoc. Biol.96 ( 4 ), 563 – 570 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Thomas TP , GoonewardenaSN , MajorosIJet al. Folate-targeted nanoparticles show efficacy in the treatment of inflammatory arthritis . Arthritis Rheum.63 ( 9 ), 2671 – 2680 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Leamon CP , ReddyJA , DortonRet al. Impact of high and low folate diets on tissue folate receptor levels and antitumor responses toward folate-drug conjugates . J. Pharmacol. Exp. Ther.327 ( 3 ), 918 – 925 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Lu Y , XuLC , ParkerNet al. Preclinical pharmacokinetics, tissue distribution, and antitumor activity of a folate-hapten conjugate-targeted immunotherapy in hapten-immunized mice . Mol. Cancer Ther.5 ( 12 ), 3258 – 3267 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Parker N , TurkMJ , WestrickE , LewisJD , LowPS , LeamonCP . Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay . Anal. Biochem.338 ( 2 ), 284 – 293 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Reddy JA , XuLC , ParkerN , VetzelM , LeamonCP . Preclinical evaluation of (99m)Tc-EC20 for imaging folate receptor-positive tumors . J. Nucl. Med.45 ( 5 ), 857 – 866 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Henne WA , KularatneSA , Ayala-LopezWet al. Synthesis and activity of folate conjugated didemnin B for potential treatment of inflammatory diseases . Bioorg. Med. Chem. Lett.22 ( 1 ), 709 – 712 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Lu Y , StinnetteTW , WestrickEet al. Treatment of experimental adjuvant arthritis with a novel folate receptor-targeted folic acid-aminopterin conjugate . Arthritis Res. Ther.13 ( 2 ), ( 2011 ).
   Web of Science ®Google Scholar
• Matteson EL , LoweVJ , PrendergastFGet al. Assessment of disease activity in rheumatoid arthritis using a novel folate targeted radiopharmaceutical Folatescan . Clin. Exp. Rheumatol.27 ( 2 ), 253 – 259 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Varghese B , HaaseN , LowPS . Depletion of folate-receptor-positive macrophages leads to alleviation of symptoms and prolonged survival in two murine models of systemic lupus erythematosus . Mol. Pharm.4 ( 5 ), 679 – 685 ( 2007 ).
   PubMedGoogle Scholar
• Jager NA , WestraJ , Van DamGMet al. Targeted folate receptor beta fluorescence imaging as a measure of inflammation to estimate vulnerability within human atherosclerotic carotid plaque . J. Nucl. Med.53 ( 8 ), 1222 – 1229 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Shen J , ChelvamV , CresswellG , LowPS . Use of folate-conjugated imaging agents to target alternatively activated macrophages in a murine model of asthma . Mol. Pharm.10 ( 5 ), 1918 – 1927 ( 2013 ).
   PubMedGoogle Scholar
• Jager NA , WestraJ , GolestaniRet al. Folate receptor-beta imaging using 99mTc-folate to explore distribution of polarized macrophage populations in human atherosclerotic plaque . J. Nucl. Med.30 ( 114 ), 143180 ( 2014 ).
   Google Scholar
• Westendorp RG , LangermansJA , HuizingaTWet al. Genetic influence on cytokine production and fatal meningococcal disease . Lancet349 ( 9046 ), 170 – 173 ( 1997 ).
   PubMed Web of Science ®Google Scholar
• Gerstner ER , DudaDG , Di TomasoEet al. VEGF inhibitors in the treatment of cerebral edema in patients with brain cancer . Nat. Rev. Clin. Oncol.6 ( 4 ), 229 – 236 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Kumar P , ShenQ , PivettiCD , LeeES , WuMH , YuanSY . Molecular mechanisms of endothelial hyperpermeability: implications in inflammation . Expert. Rev. Mol. Med.30 ( 11 ), e19 ( 2009 ).
   Google Scholar
• Baluna R , VitettaES . Vascular leak syndrome: a side effect of immunotherapy . Immunopharmacology37 ( 2–3 ), 117 – 132 ( 1997 ).
   PubMedGoogle Scholar
• Xia W , LowPS . Folate-Targeted Therapies for Cancer . J. Med. Chem.53 ( 19 ), 6811 – 6824 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• A comparison of the number of publications on nanomedicines for the treatment of cancer versus autoimmune diseases . www.pubmed.org .
   Google Scholar
• Jain JP , Yenet AyenW , DombAJ , KumarN . Biodegradable polymers in drug delivery . In : Biodegradable Polymers in Clinical Use and Clinical Development . DombAJ , KumarN , EzraA ( Eds ). John Wiley & Sons Inc. , NJ, USA , 1 – 58 ( 2011 ).
   Google Scholar